Performance of KROS (Keros Therapeutics Inc) - Total Returns
| TimeFrame |
KROS |
XBI |
| 1 Day |
3.24%
|
0.94% |
| 1 Week |
10.06% |
7.70% |
| 1 Month |
5.62% |
13.82% |
| 3 Months |
-6.61% |
-0.44% |
| 6 Months |
-31.40% |
-9.73% |
| 12 Months |
-32.29% |
-1.30% |
| YTD |
-30.30% |
-4.17% |
| Rel. Perf. 1m |
-0.72
|
|
| Rel. Perf. 3m |
-2.16
|
|
| Rel. Perf. 6m |
-2.92
|
|
| Rel. Perf. 12m |
-3.84
|
|
Comparison with the Market (Total Return): Values above 0%: KROS is performing better - Values below 0%: KROS is underperforming
|
Symbol |
1w |
1m |
6m |
12m |
| US S&P 500 |
SPY |
10.03% |
1.24% |
-38.42% |
-49.58% |
| US NADSAQ 100 |
QQQ |
11.28% |
1.33% |
-40.22% |
-69.91% |
| US Dow Jones Industrial 30 |
DIA |
8.21% |
-0.51% |
-39.90% |
-41.80% |
| German DAX 40 |
DBXD |
6.99% |
-4.46% |
-35.56% |
-47.69% |
| UK FTSE 100 |
ISFU |
9.37% |
2.34% |
-33.19% |
-39.03% |
| Shanghai Shenzhen CSI 300 |
CSI 300 |
13.01% |
10.47% |
-21.03% |
-17.89% |
| Hongkong Hang Seng |
HSI |
13.05% |
13.66% |
-20.01% |
-20.22% |
| Japan Nikkei 225 |
EXX7 |
8.36% |
2.14% |
-27.09% |
-41.50% |
| India NIFTY 50 |
INDA |
6.31% |
-1.51% |
-43.63% |
-42.23% |
| Brasil Bovespa |
EWZ |
10.50% |
0.56% |
-41.36% |
-52.83% |
| Bitcoin |
BTC |
-5.49% |
-19.24% |
-92.00% |
-188.27% |
|
Symbol |
1w |
1m |
6m |
12m |
| Communication Services |
XLC |
12.15% |
3.65% |
-39.91% |
-71.97% |
| Consumer Discretionary |
XLY |
8.89% |
-0.97% |
-39.27% |
-56.01% |
| Consumer Staples |
XLP |
9.57% |
3.53% |
-29.09% |
-27.53% |
| Energy |
XLE |
12.57% |
10.04% |
-35.47% |
-31.91% |
| Financial |
XLF |
9.30% |
-0.59% |
-40.64% |
-37.38% |
| Health Care |
XLV |
8.26% |
2.70% |
-34.02% |
-29.95% |
| Industrial |
XLI |
7.58% |
-1.48% |
-39.86% |
-43.30% |
| Materials |
XLB |
10.70% |
2.20% |
-35.03% |
-34.01% |
| Real Estate |
XLRE |
7.35% |
-3.91% |
-36.14% |
-35.72% |
| Technology |
XLK |
11.16% |
-0.15% |
-42.09% |
-73.98% |
| Utilities |
XLU |
8.17% |
2.43% |
-30.38% |
-24.77% |
| Aerospace & Defense |
XAR |
7.16% |
-1.99% |
-42.97% |
-51.95% |
| Biotech |
XBI |
2.36% |
-8.20% |
-21.67% |
-30.99% |
| Homebuilder |
XHB |
5.31% |
-7.78% |
-49.00% |
-77.46% |
| Retail |
XRT |
7.26% |
-2.18% |
-42.05% |
-36.54% |
|
Symbol |
1w |
1m |
6m |
12m |
| Oil |
USO |
20.76% |
19.17% |
-32.92% |
-31.57% |
| Natural Gas |
UNG |
18.23% |
31.43% |
-12.88% |
36.84% |
| Gold |
GLD |
10.96% |
3.17% |
-34.42% |
-46.24% |
| Silver |
SLV |
14.21% |
1.59% |
-32.69% |
-39.58% |
| Copper |
CPER |
12.68% |
5.88% |
-31.01% |
-32.38% |
|
Symbol |
1w |
1m |
6m |
12m |
| iShares 20+ Years Bond |
TLT |
6.23% |
-5.20% |
-26.74% |
-24.97% |
| iShares High Yield Corp. Bond |
HYG |
9.56% |
2.76% |
-36.15% |
-40.31% |
Why you need a Total Return Perfomance Comparison?
Comparing the Total Return of Keros Therapeutics Inc with its related sector or the XBI index is a fundamental analysis that provides investors with a comprehensive perspective on the company's performance.
Total Return encompasses not just stock price changes but also factors in dividends and other income sources, offering a more holistic view of investment outcomes.
This comparison allows investors to assess how Keros Therapeutics Inc returns stack up against the performance of its broader sector, the XBI index.
Ratings above 1 on the
Relative Performance Scale signify that the investment is performing well, while a rating exceeding 2 indicates exceptional performance.
Consequently, this analysis assists investors in making well-informed decisions about their investments by providing insights into whether Keros Therapeutics Inc is outperforming or underperforming its sector in terms of total returns.
